Theodore Lawrence Oliphant

Introduction: Theodore Lawrence Oliphant, an accomplished inventor based in Galesburg, MI, has made significant contributions to the field of biotechnology with a total of four patents to his name. His work focuses on 4-1BB binding molecules, which hold potential in enhancing therapeutic strategies.

Latest Patents: Oliphant’s recent patents exemplify his expertise and innovative approach. One of his notable patents details the development of isolated binding molecules that specifically bind to human 4-1BB. This patent encompasses not only the binding molecules themselves but also the nucleic acid sequences that encode the amino acids of these molecules, vectors comprising these nucleic acids, host cells harboring the vectors, and methodologies for producing these binding molecules. The associated pharmaceutical compositions and methods of using them further illustrate the promise of his work in medical applications.

Career Highlights: Currently employed at Pfizer Corporation, Theodore Lawrence Oliphant has leveraged his extensive knowledge in biotechnology to advance innovative solutions within the pharmaceutical industry. His dedication to research and development has propelled him to the forefront of his field.

Collaborations: Oliphant works alongside other talented professionals, including Bianca Ahrens and Sangita M Baxi. Their combined expertise fosters an environment of creativity and innovation, allowing them to push the boundaries of biopharmaceutical research.

Conclusion: Theodore Lawrence Oliphant is a notable inventor whose work on 4-1BB binding molecules highlights the intersection of innovation and biotechnology. His patents not only contribute to the scientific community but also stand to impact the future of therapeutic treatments, exemplifying the vital role of inventors in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.